vs

Side-by-side financial comparison of Inogen Inc (INGN) and ZIPRECRUITER, INC. (ZIP). Click either name above to swap in a different company.

ZIPRECRUITER, INC. is the larger business by last-quarter revenue ($111.7M vs $68.6M, roughly 1.6× Inogen Inc). On growth, Inogen Inc posted the faster year-over-year revenue change (3.4% vs 0.6%). ZIPRECRUITER, INC. produced more free cash flow last quarter ($7.6M vs $-1.9M). Over the past eight quarters, Inogen Inc's revenue compounded faster (4.2% CAGR vs -4.4%).

Inogen Inc is a medical technology firm specializing in the development, production and distribution of portable oxygen concentrators and associated respiratory care products. It caters primarily to patients with chronic respiratory conditions needing long-term oxygen therapy across North America, Europe and other global markets, focusing on home care and ambulatory patient segments to enhance users' quality of life.

INGN vs ZIP — Head-to-Head

Bigger by revenue
ZIP
ZIP
1.6× larger
ZIP
$111.7M
$68.6M
INGN
Growing faster (revenue YoY)
INGN
INGN
+2.8% gap
INGN
3.4%
0.6%
ZIP
More free cash flow
ZIP
ZIP
$9.5M more FCF
ZIP
$7.6M
$-1.9M
INGN
Faster 2-yr revenue CAGR
INGN
INGN
Annualised
INGN
4.2%
-4.4%
ZIP

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
INGN
INGN
ZIP
ZIP
Revenue
$68.6M
$111.7M
Net Profit
$-835.0K
Gross Margin
51.4%
89.1%
Operating Margin
-13.6%
3.6%
Net Margin
-0.7%
Revenue YoY
3.4%
0.6%
Net Profit YoY
92.3%
EPS (diluted)
$-0.26
$-0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INGN
INGN
ZIP
ZIP
Q4 25
$68.6M
$111.7M
Q3 25
$79.1M
$115.0M
Q2 25
$79.2M
$112.2M
Q1 25
$68.5M
$110.1M
Q4 24
$66.3M
$111.0M
Q3 24
$74.9M
$117.1M
Q2 24
$74.4M
$123.7M
Q1 24
$63.1M
$122.2M
Net Profit
INGN
INGN
ZIP
ZIP
Q4 25
$-835.0K
Q3 25
$-5.3M
$-9.8M
Q2 25
$-4.2M
$-9.5M
Q1 25
$-6.2M
$-12.8M
Q4 24
$-10.8M
Q3 24
$-6.0M
$-2.6M
Q2 24
$-5.6M
$7.0M
Q1 24
$-14.6M
$-6.5M
Gross Margin
INGN
INGN
ZIP
ZIP
Q4 25
51.4%
89.1%
Q3 25
52.2%
89.1%
Q2 25
52.2%
89.3%
Q1 25
53.1%
89.4%
Q4 24
54.7%
89.6%
Q3 24
55.2%
89.4%
Q2 24
57.4%
89.5%
Q1 24
54.5%
89.1%
Operating Margin
INGN
INGN
ZIP
ZIP
Q4 25
-13.6%
3.6%
Q3 25
-9.0%
-4.4%
Q2 25
-7.7%
-5.9%
Q1 25
-11.2%
-10.6%
Q4 24
-17.2%
-3.6%
Q3 24
-10.4%
-2.8%
Q2 24
-9.5%
7.6%
Q1 24
-25.8%
-0.7%
Net Margin
INGN
INGN
ZIP
ZIP
Q4 25
-0.7%
Q3 25
-6.7%
-8.5%
Q2 25
-5.2%
-8.5%
Q1 25
-9.0%
-11.7%
Q4 24
-9.7%
Q3 24
-8.0%
-2.2%
Q2 24
-7.5%
5.7%
Q1 24
-23.1%
-5.3%
EPS (diluted)
INGN
INGN
ZIP
ZIP
Q4 25
$-0.26
$-0.03
Q3 25
$-0.20
$-0.11
Q2 25
$-0.15
$-0.10
Q1 25
$-0.25
$-0.13
Q4 24
$-0.41
$-0.10
Q3 24
$-0.25
$-0.03
Q2 24
$-0.24
$0.07
Q1 24
$-0.62
$-0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INGN
INGN
ZIP
ZIP
Cash + ST InvestmentsLiquidity on hand
$103.7M
$188.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$192.2M
$-77.2M
Total Assets
$298.6M
$569.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INGN
INGN
ZIP
ZIP
Q4 25
$103.7M
$188.0M
Q3 25
$106.5M
$211.8M
Q2 25
$103.7M
$203.5M
Q1 25
$118.9M
$221.1M
Q4 24
$113.8M
$218.4M
Q3 24
$105.7M
$225.6M
Q2 24
$97.9M
$271.7M
Q1 24
$107.4M
$282.5M
Stockholders' Equity
INGN
INGN
ZIP
ZIP
Q4 25
$192.2M
$-77.2M
Q3 25
$197.2M
$-76.1M
Q2 25
$199.5M
$-65.9M
Q1 25
$198.0M
$-11.3M
Q4 24
$173.9M
$13.4M
Q3 24
$185.4M
$13.6M
Q2 24
$187.6M
$24.4M
Q1 24
$191.9M
$12.7M
Total Assets
INGN
INGN
ZIP
ZIP
Q4 25
$298.6M
$569.7M
Q3 25
$307.0M
$573.6M
Q2 25
$312.0M
$592.4M
Q1 25
$308.4M
$629.4M
Q4 24
$296.2M
$664.1M
Q3 24
$306.2M
$652.0M
Q2 24
$308.9M
$665.3M
Q1 24
$315.6M
$662.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INGN
INGN
ZIP
ZIP
Operating Cash FlowLast quarter
$-943.0K
$7.7M
Free Cash FlowOCF − Capex
$-1.9M
$7.6M
FCF MarginFCF / Revenue
-2.8%
6.8%
Capex IntensityCapex / Revenue
1.4%
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-13.7M
$9.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INGN
INGN
ZIP
ZIP
Q4 25
$-943.0K
$7.7M
Q3 25
$2.2M
$2.6M
Q2 25
$4.3M
$10.5M
Q1 25
$-16.8M
$-9.9M
Q4 24
$-3.0M
$12.5M
Q3 24
$7.0M
$9.3M
Q2 24
$6.7M
$21.9M
Q1 24
$-4.7M
$2.0M
Free Cash Flow
INGN
INGN
ZIP
ZIP
Q4 25
$-1.9M
$7.6M
Q3 25
$1.6M
$2.2M
Q2 25
$3.7M
$10.2M
Q1 25
$-17.1M
$-10.2M
Q4 24
$-3.3M
$12.0M
Q3 24
$5.3M
$9.2M
Q2 24
$6.6M
$21.7M
Q1 24
$-6.1M
$1.9M
FCF Margin
INGN
INGN
ZIP
ZIP
Q4 25
-2.8%
6.8%
Q3 25
2.0%
1.9%
Q2 25
4.6%
9.1%
Q1 25
-24.9%
-9.3%
Q4 24
-5.0%
10.8%
Q3 24
7.1%
7.8%
Q2 24
8.9%
17.6%
Q1 24
-9.6%
1.6%
Capex Intensity
INGN
INGN
ZIP
ZIP
Q4 25
1.4%
0.1%
Q3 25
0.7%
0.3%
Q2 25
0.9%
0.3%
Q1 25
0.4%
0.3%
Q4 24
0.5%
0.4%
Q3 24
2.2%
0.2%
Q2 24
0.1%
0.1%
Q1 24
2.1%
0.1%
Cash Conversion
INGN
INGN
ZIP
ZIP
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
3.12×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

INGN
INGN

Other$36.1M53%
Non Us$32.5M47%

ZIP
ZIP

License$84.3M75%
Services$27.4M25%

Related Comparisons